Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Lorentino F, Xue E, Mastaglio S, Giglio F, Clerici D, Farina F, Piemontese S, Bruno A, Lazzari L, Ruggeri A, Guggiari E, Lunghi F, Assanelli AA, Marktel S, Marcatti M, Carrabba MG, Bernardi M, Corti C, Peccatori J, Ciceri F, Greco R, Lupo-Stanghellini MT.
Lorentino F, et al. Among authors: bruno a.
Blood Adv. 2022 May 24;6(10):3053-3057. doi: 10.1182/bloodadvances.2021006213.
Blood Adv. 2022.
PMID: 35078219
Free PMC article.
No abstract available.